US Stock MarketDetailed Quotes

FOLD Amicus Therapeutics

Watchlist
  • 9.420
  • +0.110+1.18%
Trading Jan 3 12:41 ET
2.81BMarket Cap-27.71P/E (TTM)

Amicus Therapeutics Key Stats

Amicus Therapeutics Q3 2024 Earnings Date

Currency:USDNov 6, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
134.96M
141.52M
+6.55M
Beat Est.
+30.40%
+36.73%
+4.86%
EPS
<0.01
-0.02
-0.02
Miss Est.
+101.72%
+71.43%
-1766.67%
Strong Buy

Dec 31, 2024

Amicus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 141.999M--
--2024/Q4-- / 147.374M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 141.999M--
--2024/Q4-- / 147.374M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--

Unlock Free Earnings Estimates

Amicus Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

No Data